Hydrochlorothiazide
Product Images NDC 10544-197

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 10544-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

12-5mg 30ct (Label Hydrochlorothiazide Caps 12 5mg Bpi(10544 197 30) Watson(0591 0347 05) Rev0)

12-5mg 30ct (Label Hydrochlorothiazide Caps 12 5mg Bpi(10544 197 30) Watson(0591 0347 05) Rev0)
This text contains information about a medication called Hydrochlorothiazide Capsules of 12.5mg and 25mg. The capsules come in a container with 30 capsules. It includes details about the manufacturer, NDC number, lot number, and expiration date of the medication. The recommended dosage and storage conditions are also mentioned. It is advised to keep the medication out of the reach of children and to protect it from moisture and freezing. At the end of the text, two regulatory agencies are mentioned, B Pramesa 1 and Watson Pharma Private Limited. However, there is a considerable amount of missing information and incorrect spellings, which may make it difficult to make informed decisions based on the text.*
FDA Label Image

Structure (Hydrochlorothiazide Capsule 1)

Structure (Hydrochlorothiazide Capsule 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.